ReviewCancer immunology, immunotherapy : CII2017
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.
Marcin Kortylewski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it